News Report: Blood-Testing Startup Theranos Will Liquidate, Shut Down

(September 5, 2018, 12:22 PM EDT) -- NEW YORK — The Wall Street Journal reported Sept. 4 that beleaguered blood-testing startup Theranos Inc. told stockholders in a letter that it will turn over its intellectual property to an investment group, pay unsecured creditors about $5 million, assign remaining assets to a third party for distribution to creditors but not stockholders and then dissolve the company....

Related Sections